| Schedule of Warrants Outstanding |
As of December 31, 2020 and 2019, the Company had warrants outstanding to purchase the underlying number of shares of common stock as shown in the table below.
|
|
|
|
|
|
|
|
|
| |
|
December 31, |
|
| |
|
2020 |
|
|
2019 |
|
|
|
|
8,842,464 |
|
|
|
— |
|
|
|
|
1,599,645 |
|
|
|
1,599,645 |
|
|
|
|
1,400,000 |
|
|
|
1,400,000 |
|
|
|
|
505,617 |
|
|
|
— |
|
|
|
|
— |
|
|
|
18,915 |
|
|
|
|
2,567 |
|
|
|
15,350 |
|
| |
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
12,350,293 |
|
|
|
3,033,910 |
|
Weighted-average exercise price per share |
|
$ |
9.14 |
|
|
$ |
22.61 |
|
| (1) |
Other warrants are comprised of warrants issued prior to the Company’s IPO, generally in exchange for services rendered to the Company. |
The following table summarizes information regarding the Company’s warrants outstanding and the corresponding exercise price at December 31, 2020:
|
|
|
|
|
|
|
|
|
Shares
Underlying
Outstanding
Warrants |
|
|
|
|
|
|
9,348,652 |
|
|
September 1, 2021 – May 27, 2023 |
|
|
|
1,599,645 |
|
|
July 25, 2022 |
|
|
|
1,401,996 |
|
|
January 3, 2021 - January 5, 2022 |
| |
|
|
|
|
|
|
| |
|
|
12,350,293 |
|
|
|
| |
|
|
|
|
|
|